Arvinas Ownership | Who Owns Arvinas?

Overview Forecast RevenueFinancials Chart Transcripts

Arvinas Ownership Summary

Arvinas is owned by 45.53% institutional investors, 7.88% insiders, and 46.59% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.04% of ARVN shares. BB Biotech AG Ord is the top mutual fund, with 3.46% of its assets in Arvinas shares.

ARVN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Arvinas	45.53%	7.88%	46.59%
Sector	Healthcare Stocks	232.51%	10.72%	-143.23%
Industry	Biotech Stocks	384.56%	10.58%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	7.32M	10.04%	$86.84M
Vanguard group	7.23M	9.92%	$85.74M
Blackrock	6.26M	8.70%	$166.61M
Logos global management lp	5.58M	7.66%	$47.50M
Pfizer	3.46M	4.74%	$41.01M
State street	1.87M	2.57%	$15.96M
Geode capital management	1.62M	2.23%	$19.26M
Tcg crossover management	1.62M	2.22%	$13.78M
New leaf venture partners	1.59M	2.18%	$13.51M
Qube research	1.49M	2.04%	$12.67M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.59M	31.38%	$13.51M
Pfizer	3.46M	17.34%	$41.01M
Brummer multi-strategy ab	166.34K	11.93%	$1.97M
Aquilo capital management	328.77K	9.50%	$6.30M
Rangeley capital	695.40K	5.13%	$5.92M
Nextech invest	1.41M	4.38%	$27.00M
Logos global management lp	5.58M	4.26%	$47.50M
Arbiter partners capital management	452.79K	2.62%	$5.37M
Nextech invest	1.41M	1.83%	$12.00M
Opaleye management	987.82K	1.19%	$8.42M

Top Buyers

Holder	Shares	% Assets	Change
Logos global management lp	5.58M	4.26%	2.27M
Tcg crossover management	1.62M	0.68%	1.62M
Norges bank	1.24M	0.00%	1.24M
Qube research	1.49M	0.01%	903.34K
Blackrock	6.26M	0.00%	764.55K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-6.73M
Rtw investments, lp	-	-	-3.33M
Bellevue group	-	-	-2.39M
Paradigm biocapital advisors lp	-	-	-2.34M
Alyeska investment group	-	-	-1.80M

New Positions

Holder	Shares	% Assets	Change	Value
Tcg crossover management	1.62M	0.68%	1.62M	$13.78M
Norges bank	1.24M	0.00%	1.24M	$23.84M
Nantahala capital management	300.00K	0.12%	300.00K	$3.56M
Susquehanna portfolio strategies	273.69K	0.04%	273.69K	$2.33M
Brummer multi-strategy ab	166.34K	11.93%	166.34K	$1.97M

Sold Out

Holder	Change
Truvestments capital	-1.00
Capital performance advisors llp	-6.00
Turning point benefit group	-7.00
Smartleaf asset management	-8.00
Principal securities	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	124	-44.14%	33,193,014	-50.49%	45	0.54%	57	-47.22%	41	-40.58%
Sep 30, 2025	210	-4.98%	63,374,662	4.16%	87	1.25%	101	-20.47%	66	29.41%
Jun 30, 2025	229	1.33%	69,799,900	12.46%	95	1.31%	130	2.36%	52	-10.34%
Mar 31, 2025	227	7.08%	64,055,484	-16.35%	88	0.78%	127	13.39%	58	13.73%
Dec 31, 2024	208	-4.59%	76,287,067	7.32%	105	1.09%	111	9.90%	51	-22.73%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	2.38M	3.46%	-
Vanguard US Total Market Shares ETF	1.93M	2.81%	2.43K
Vanguard Total Stock Mkt Idx Inv	2.01M	2.75%	-44.64K
iShares Russell 2000 ETF	1.60M	2.18%	-
Vanguard Explorer Inv	1.56M	2.13%	683.33K
Vanguard Strategic Equity Inv	1.25M	1.71%	594.88K
Vanguard Small Cap Index	841.18K	1.15%	-5.64K
JPMorgan Small Cap Growth A	755.08K	1.10%	-8.49K
T. Rowe Price Small-Cap Stock	702.69K	1.02%	94.70K
Vanguard Institutional Extnd Mkt Idx Tr	747.55K	1.02%	-326.16K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 13, 2026	Teel Randy	President and CEO	Sell	$52.35K
Feb 13, 2026	Saik Andrew	Chief Financial Officer	Sell	$61.04K
Feb 13, 2026	Cacace Angela M	Chief Scientific Officer	Sell	$54.60K
Feb 13, 2026	Berkowitz Noah	Chief Medical Officer	Sell	$67.59K
Feb 13, 2026	Loomis David K	Chief Accounting Officer	Sell	$12.08K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	1
2025 Q3	1	-
2025 Q2	-	2
2025 Q1	-	8
2024 Q4	-	1

ARVN Ownership FAQ

Who Owns Arvinas?

Arvinas shareholders are primarily institutional investors at 45.53%, followed by 7.88% insiders and 46.59% retail investors. The average institutional ownership in Arvinas's industry, Biotech Stocks , is 384.56%, which Arvinas falls below.

Who owns the most shares of Arvinas?

Arvinas’s largest shareholders are Blackrock funding, inc. /de (7.32M shares, 10.04%), Vanguard group (7.23M shares, 9.92%), and Blackrock (6.26M shares, 8.70%). Together, they hold 28.67% of Arvinas’s total shares outstanding.

Does Blackrock own Arvinas?

Yes, BlackRock owns 8.70% of Arvinas, totaling 6.26M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 166.61M$. In the last quarter, BlackRock increased its holdings by 764.55K shares, a 13.92% change.

Who is Arvinas’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Arvinas’s biggest shareholder by percentage of total assets invested, with 31.38% of its assets in 1.59M Arvinas shares, valued at 13.51M$.

Who is the top mutual fund holder of Arvinas shares?

BB Biotech AG Ord is the top mutual fund holder of Arvinas shares, with 3.46% of its total shares outstanding invested in 2.38M Arvinas shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools